I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

Engineer 1 - Project

Full-TimeUpdated on 10/15/2026Deadline 11/27/26
No salary listed
Entry, Junior, Mid
Bachelor's
Montevideo, Montevideo Department, Uruguay
In Person
Project & Program ManagementProject Management

About the job

Requirements
  • You have earned, as a minimum, a bachelor's degree in an engineering or related technical field and have between 0–3 years of experience.
  • Candidates who do not meet the education requirement may be considered with 5+ years of relevant experience.
  • You must be able to work independently and collaboratively with other associates and cross-functional teams.
  • You must demonstrate technical aptitude to contribute to a team or produce technical results individually.
  • You must demonstrate written and oral communication competencies.
  • You must maintain a calm demeanor in a high-energy, changing production environment.
  • You must have an intermediate-to-advanced conversational, written, and reading proficiency in English.
  • You need 0–3 years of experience in manufacturing, engineering, or project management.
  • You need knowledge of engineering project administration and tracking, manufacturing processes, equipment/process/product validation, technical documentation, work instructions, and coordinating implementation and process-improvement activities.
  • You need advanced Microsoft Office skills, especially Excel.
  • You need organizational, analytical, and problem-solving abilities, and the ability to work in multidisciplinary teams while managing multiple activities.
Responsibilities
  • Select and apply standard engineering techniques, procedures, and criteria to adapt and modify existing products and processes under experienced engineers’ supervision.
  • Review procedures and plans before implementation and evaluate existing products, processes, and materials for failure analysis and potential improvements.
  • Participate in moderately complex projects to investigate, develop, document, and implement new product and process technologies.
  • Perform technical project work using standard quality-management and production-system methodologies to investigate product and process improvement opportunities.
  • Apply data-analysis practices and techniques to establish root causes of product and process failures or support improvement justifications.
  • Observe products and processes, recognize discrepancies in results, and follow detailed operations to establish root causes.
  • Collaborate with others, exchange information, ask questions, and check for understanding in support of professional development.
  • Assure adherence to the Quality Management System, facilitate or contribute to corrective and preventive actions, and contribute to quality key performance indicators and the journey to 5 Sigma.
  • Develop and deploy systems and tools that drive innovation and continuous improvement.
  • Support Manufacturing Excellence practices through site Hoshin plans, Sales, Inventory, and Operations Planning meetings, value stream map updates, production monitoring and improvement, Leader Standard Work, workplace organization and visual controls (5S), Manufacturing Standard Work, training and certification, standardized problem solving, behavior-based safety, improvement idea systems, built-in quality, optimized scheduling and material systems, work-cell design, and total productive maintenance.
  • Support Integer Environmental, Health & Safety programs and achieve defined project goals, milestones, and site quality key performance indicators.
  • Generate continuous-improvement suggestions and support their implementation.
  • Plan and execute strategic manufacturing projects that introduce new products, equipment, or materials within budget and schedule.
  • Lead and collaborate with cross-functional teams in project development and implementation, including procurement, installation, commissioning, and qualification.
  • Identify outside vendors for required services and ensure compliance with project requirements, specifications, and schedules.
  • Develop project budgets and schedules and prepare appropriate capital appropriation request documentation.
  • Provide project-engineering support and expertise across the global organization as needed.
  • Lead and track engineering projects from planning through implementation.
  • Coordinate installation, validation, and commissioning of manufacturing equipment and processes.
  • Participate in transferring and introducing new products into production.
  • Coordinate suppliers, contractors, and internal teams involved in projects.
  • Collaborate with Quality, Manufacturing, Production, Purchasing, Maintenance, and Supply Chain teams.
  • Ensure projects meet established quality, cost, and schedule objectives.
  • Track project progress and present results to management and leadership teams.
  • Identify continuous-improvement opportunities that contribute to operational and production efficiency.
  • Perform other duties as directed by line supervision.
Desired Qualifications
  • Experience in the medical industry or regulated environments is desirable.
  • Knowledge of quality standards and systems applicable to the medical industry, including FDA, ISO 13485, or GMP, is desirable.
  • Knowledge of Microsoft Project or similar project-management tools is desirable.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

-1%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.